Integrative analysis identifies miR-183-3p as a candidate ESR1 3′-UTR-binding microRNA in colorectal cancer

MicroRNA-183-3p (miR-183-3p) is dysregulated in colorectal cancer (CRC), but its downstream targets and biological relevance remain incompletely defined. We investigated the potential relationship between miR-183-3p and estrogen receptor 1 ( ESR1 ) using an integrative, hypothesis-generating framework. Differentially expressed miRNAs were identified by small-RNA sequencing of paired CRC and adjacent tissues. Exploratory two-sample Mendelian randomization (MR) used circulating miRNA expression quantitative trait loci and four FinnGen CRC-related outcomes. Candidate targets were prioritized by target prediction, protein-protein interaction analysis, functional enrichment, and an expanded experimentally supported miRNA-target network. miR-183-3p and ESR1 expression were evaluated in an independent six-pair tissue cohort, with external validation in TCGA-COAD and TCGA-READ. Direct binding to the ESR1 3′-UTR was assessed by dual-luciferase assay in HEK293T cells, and overall survival was explored in TCGA cohorts. miR-183-3p was upregulated and ESR1 mRNA was downregulated in CRC tissues. MR showed a nominal association between genetically predicted circulating miR-183-3p and colon carcinoma in situ (IVW OR = 1.28, 95% CI 1.02–1.60, P = 0.037), but the association did not survive FDR correction (adjusted P = 0.074) or receive support from alternative estimators. ESR1 was prioritized as a candidate target, and expanded network analysis placed the miR-183-3p– ESR1 interaction within a broader many-to-many regulatory architecture. In six tumor samples, miR-183-3p and ESR1 mRNA showed a nonsignificant inverse association (Spearman ρ = −0.829, P = 0.058). Modest inverse associations were reproduced in TCGA-COAD ( n = 443, ρ = −0.219, P < 0.001) and TCGA-READ ( n = 160, ρ = −0.279, P < 0.001). miR-183-3p directly bound the ESR1 3′-UTR and suppressed reporter activity in HEK293T cells. Mature miR-183-3p and ESR1 were not significantly associated with overall survival in the evaluated TCGA cohorts. The findings support miR-183-3p as a candidate ESR1 3′-UTR-binding miRNA in CRC. However, the MR evidence remains exploratory, and functional repression of endogenous ESR1 in CRC cells remains unproven.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-10-26
DOI
https://doi.org/10.1186/s12885-026-17250-1
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrative analysis identifies miR-183-3p as a candidate ESR1 3′-UTR-binding microRNA in colorectal cancer

Song Wang, Xiaoqian Zhao, Yunlong Sun, Dongping Lai et al.
BMC Cancer
MicroRNA in disease regulation
article

Integrative analysis identifies miR-183-3p as a candidate ESR1 3′-UTR-binding microRNA in colorectal cancer

Song Wang, Xiaoqian Zhao, Yunlong Sun, Dongping Lai, Weixuan Lan, Yunsi Huang, Xin Yao, Hao Li, Xuedong Han, Tao Zhang
article en

Abstract

MicroRNA-183-3p (miR-183-3p) is dysregulated in colorectal cancer (CRC), but its downstream targets and biological relevance remain incompletely defined. We investigated the potential relationship between miR-183-3p and estrogen receptor 1 ( ESR1 ) using an integrative, hypothesis-generating framework. Differentially expressed miRNAs were identified by small-RNA sequencing of paired CRC and adjacent tissues. Exploratory two-sample Mendelian randomization (MR) used circulating miRNA expression quantitative trait loci and four FinnGen CRC-related outcomes. Candidate targets were prioritized by target prediction, protein-protein interaction analysis, functional enrichment, and an expanded experimentally supported miRNA-target network. miR-183-3p and ESR1 expression were evaluated in an independent six-pair tissue cohort, with external validation in TCGA-COAD and TCGA-READ. Direct binding to the ESR1 3′-UTR was assessed by dual-luciferase assay in HEK293T cells, and overall survival was explored in TCGA cohorts. miR-183-3p was upregulated and ESR1 mRNA was downregulated in CRC tissues. MR showed a nominal association between genetically predicted circulating miR-183-3p and colon carcinoma in situ (IVW OR = 1.28, 95% CI 1.02–1.60, P = 0.037), but the association did not survive FDR correction (adjusted P = 0.074) or receive support from alternative estimators. ESR1 was prioritized as a candidate target, and expanded network analysis placed the miR-183-3p– ESR1 interaction within a broader many-to-many regulatory architecture. In six tumor samples, miR-183-3p and ESR1 mRNA showed a nonsignificant inverse association (Spearman ρ = −0.829, P = 0.058). Modest inverse associations were reproduced in TCGA-COAD ( n = 443, ρ = −0.219, P < 0.001) and TCGA-READ ( n = 160, ρ = −0.279, P < 0.001). miR-183-3p directly bound the ESR1 3′-UTR and suppressed reporter activity in HEK293T cells. Mature miR-183-3p and ESR1 were not significantly associated with overall survival in the evaluated TCGA cohorts. The findings support miR-183-3p as a candidate ESR1 3′-UTR-binding miRNA in CRC. However, the MR evidence remains exploratory, and functional repression of endogenous ESR1 in CRC cells remains unproven.

BMC Cancer
Nanjing University of Chinese Medicine (CN), Guangxi University (CN), Guangxi University of Chinese Medicine (CN), The Second Nanning People's Hospital (CN), Wuxi Taihu Hospital (CN)
Openalex Percentile: Top 17%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon